Ivantis Hydrus® Microstent
This Hydrus microstent makes it possible to be treated for glaucoma at the same time you have cataract surgery. The stent continuously reduces eye pressure.
Overview
The Hydrus Microstent is an FDA-approved stent that works by controlling intraocular pressure (IOP), which can lead to vision loss and blindness if left untreated.
Uses and Applications
The Hydrus Microstent helps to reduce the risk of vision loss and blindness by controlling eye pressure. It works by enhancing the outflow of eye fluids through the implant, expanding the natural fluid pathway (Schlemm’s canal), and reducing eye pressure. The stent ensures that eye fluid can travel from Schlemm’s canal to the blood system to avoid pressure buildup which can damage the eyes and is suitable for patients with mild to moderate open-angle Glaucoma
Features and Benefits
The Hydrus Microstent is a highly flexible device that is about half the diameter of a penny, or the size of an eyelash. It comes preloaded in a stainless-steel cannula. The ophthalmologist will implant the stent through a microscopic incision with advanced surgical equipment. As a result, pressure is reduced once the fluids immediately start to drain.
- Less Invasive Procedure – faster healing
- Effective Pressure Control
